chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021; No adverse event; patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event) in a 28-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021).    No concomitant medications were reported. It was reported that total 12 patients received the Monovalent expired dose of vaccine, it was their first booster dose of Moderna COVID-19 vaccine. There were 12 doses with vial size 5.5 ml. The vial was initially stored in the refrigerator on 12-Nov-2021. The vial did not undergo any temperature excursions. No treatment details were reported.
Extreme joint aches - my wrist and my ankle - mainly: Extreme tendonitis feeling. Nothing I normally experience. Felt extremely inflamed - I couldn't do push ups. My right ankle swelled up pretty extreme. I had not been running or anything.  Sometimes it would hurt my foot, and another day my right wrist would bother me and then the next day the other wrist. My knees bothered me a little bit too. It was an achy, dull pain. My knees sometimes bother me anyway but this was a bit different.  I called my PCM - she told me that I could take Motrin or Ibuprofen - and use cold compress or apply heat. My ankle was just one night and it went away the next day. My wrists bothered me for about a full week or so. That was pretty hindering - I couldn't pick up my children.  For the first dose - I had an extreme level of fatigue for about 24 hours - the first 48 hours after vaccine. I felt bodily and mentally tired. I stayed in bed and hydrated for two straight days. The second vaccine I had no reaction.
Both the dose of the drug was taken on the same date that is 24Feb2021; Higher blood pressure. Hypertension; This is a spontaneous report from a contactable consumer (patient). A 67-year-old elderly non-pregnat female patient received first and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6203), via unspecified route of administration in the Left arm, on 24Feb2021 at 01:00 PM, as a single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. On 24Feb2021 at 01:15 PM, the patient experienced higher blood pressure. The patient did not received treatment for the events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
felt their legs were numb; weakness; fell to floor because of numbness; had fever and chills; extreme fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills) and FATIGUE (extreme fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Dec-2020.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills), FATIGUE (extreme fatigue) and CHILLS (chills). At the time of the report, HYPOAESTHESIA (felt their legs were numb), ASTHENIA (weakness), FALL (fell to floor because of numbness), PYREXIA (had fever and chills), FATIGUE (extreme fatigue) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2020, SARS-CoV-2 test: (Positive) tested positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided   Reporter did not allow further contact
Patient's caregiver called us on 10/7/2021 to inform us that patient passed away at 1 am on 10/03/2021 from a heart attack. He had mild redness at the site of injection. No flu like symptoms or fever after receiving the shot.
febrile sz lasting approx 1min;low grade fever lasting 8 days;after CXR & blood work;fever was found to be of unk origin;
one got very sick from the vaccine; vomiting; fever; chills; This case was reported by a consumer via  interactive digital media and described the occurrence of sickness in a patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced sickness, vomiting, fever and chills. On an unknown date, the outcome of the sickness, vomiting, fever and chills were recovered/resolved.   It was unknown if the reporter considered the sickness, vomiting, fever and chills to be related to Meningococcal B vaccine.  Additional details were provided as follows: The patient was reporter's son/daughter. The age at vaccination was not reported. The patient got very sick from the vaccine and he/she experienced vomiting, fever, chills but it was only lasted about 48 hours. The reporter mentioned that, his/her brother almost died from this, that's why he/she chose to vaccinate his/her kids. The follow-up would not possible, as no contact details were available. This case had been linked with US2021AMR074596, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR074596:same reporter
Patient received a 1st dose Moderna Covid 19 vaccine on 03/23/2021. Lot# 002B21A injected IM into the left arm. This was a clinic that offered both Pfizer and Moderna 1st doses. The patient was told that he received Moderna and the providing facility would contact him with an appointment time and date for his second dose. The Pfizer recipients were all instructed to come on 4/13/21 for their second doses at the same appointment time as they had for the first dose. This recipient stated when we called him to schedule his 2nd Moderna dose that he had already gotten his second shot, but if he  needed to he would get a 3rd dose. Upon investigation, it was discovered he received the Pfizer as a second dose. The patient did not report any adverse reactions.
Information has been received from a physician concerning an 18 year old male patient who on 26-AUG-1992 was vaccinated with a first dose of MMR II (route and lot number not reported). On 14-OCT-2009 the patient was vaccinated with a second dose of MMR II. On 04-DEC-2009 the patient experienced and was diagnosed with mumps (thought the date diagnosed was reported as 04-DEC-2009). Other symptoms presented by the patient included left parotitis. On 04-DEC-2009 the patient had a blood work done (results not reported). The patient was afebrile. The patient's outcome was unknown. This is of several reports from the same source. No further information is available.
She started having trouble breathing and walk-in shortly after having the boaster shot. It?s been discovered her iron has been dangerous low and she required an emergency blood transfusion. She has never had an isksue with iron until after the booster shot. She is still doing more tests to attempt to determine the call. Her nurse suggested we report this
Received First Dose of Heplisav-B and Second Dose with Engerix; Initial Report Received on 11-Jun-2021  An advanced nurse practitioner reported that a 24 year-old female (race and ethnicity not provided) received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and Engerix as the second dose of the series.  No relevant medical history was reported. The patient had no known allergies.   No relevant concomitant medications were reported.  On 27-Apr-2021, the patient received the first dose of HEPLISAV-B from a medical doctor's office (Lot # 934599, expiration date 22-Feb-2022, NDC # 43528-0003-05; route and site were not reported).   On 09-Jun-2021, the patient received the second dose with Engerix.   At the time of reporting, no adverse effects were reported. No other information was provided.    Company Comment:  The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Unspecific Adverse Event; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Unspecific Adverse Event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Unspecific Adverse Event). At the time of the report, ADVERSE EVENT (Unspecific Adverse Event) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Began fever and illness on December 13, 2019. She started to get fussing than usual, unable to drink well, fever started. Took in to be told it was viral and nothing could be done to keep giving tylenol and trying to get her to drink. December 16 2019 took her in again to be told maybe it was URI and now a GI virus due to her having a couple episodes of throwing up and diarrhea like poop. Took in December 19 2019 to be diagnosed with double ear infection and put on augmentin. Also had labs and urine checked due to less wet diapers. Urine normal and labs showed minimal elevation of wbcs and neutrophils. Illness persisted along with fever and lethargy and paleness. December 22 and 23 2019 took in due to fever persisting and tylenol not really helping. Was told it didn't pay to do another work up as it was just done and it wouldn't show much change. December 24 2019 unsure if patient had seizure or not, was very irritable and crying out as if in pain. December 25 2019 absence like seizure activity occurred and she was sleeping oddly overnight. December 26 2019 took in again to be told to go to higher level care facility where then while in emergency dept had true seizure and found out there was fluid around the brain and then once that resolved with a subdural peritoneal shunt she developed hydrocephalus in the ventricles which they intervened with a endoscopic third ventriculostomy. Daughter still had enlarged ventricles at last mri in April 2020 but is developmentally doing well.
This was my 4th pregnancy. All previous pregnancy were low risk and babies came near due date. With this pregnancy, my water broke at 33 weeks and I gave birth at 33 weeks and 6 days gestation. The placenta looked deteriorated and was sent to pathology. Baby girl weight 4 lb 4 oz.
Pfizer on 4/3 and 4/23. Positive on 9/12
Information has been received from the mother of a male who on an unspecified date was vaccinated with Hep-B vaccine recombinant (yeast) (lot 624812/1226E). Concomitant therapy included MMRII (lot 628551/1184H) (date of vaccination not reported) and HIB conjugate vaccine (lot 626192/0164H) (date of vaccination not reported). It was reported that the pt subsequently, developed autism. Upon internal review, the pt's autism was considered to be an "Other Important Medical Event". Additional information has been received.
BODY ACHES; CHILLS; FATIGUE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue, body aches and chills was not reported. This report was non-serious.
had tonic episode w/staring lasting about 1-2min 8hr p/vax;no fever;blood work & spinal tap done in ER;adm to hosp x 24hr;no further spells or sz noted;workup all WNL;
My wife came down with COVID-19 on 10/16/2022. I began to feel a scratchy throat and felt a bit poor that day as well. The next morning, I was feeling worse, so I tested for COVID-19 and was negative, but later that day, I tested again and was positive. I informed my doctor that I was positive for COVID-19. They responded within an hour or so to inform me that he was prescribing Paxlovid for me to begin right away. Ever since then, I have been taking that as prescribed. I am three days into it now. The symptoms have subsided but are not gone completely. Along with the sore throat, I was experiencing a runny nose, and feeling of irritation in the middle of my chest. I can't say that it was painful necessarily but more similar to a congestion. Everything seems to have pretty much gone away with the exception of an occasional cough. I feel tired and sort of not myself, but I'm not feeling majorly ill. I have two more days of the medication and expect it to be over with by then.
Appendicitis 11 days after vaccination; This is a spontaneous report from a non-contactable consumer (patient). A 39-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 14Sep2021 (at the age of 39-years-old) (Batch/Lot number was not reported) as single for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have concomitant medications or other medications received within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had appendicitis 11 days after vaccination (as reported) (also reported as 24Sep2021). The patient had a negative nasal swab on 24Sep2021. The patient required emergency room/department or urgent care. The patient received surgery as treatment for the event. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a licensed visiting nurse concerning a 9 week old female who on 30-APR-2007 was vaccinated with Rotateq (lot number reported as unavailable). Concomitant vaccines included DTP, Comvax, Recombivax, Poliovirus vaccine, Prevnar. On 03-MAY-2007 the nurse reported that the "patient experienced terrible vomiting and diarrhea (smelly, brown and liquidy)" and low temperature after receiving ROTATEQ. The patient sought unspecified medical attention. On an unspecified date, the patient recovered from terrible vomiting, "diarrhea (smelly, brown and liquidy)" and low temperature. There was no product quality complaint involved. Additional information has been requested.
11 days p/vax pt felt warm; parents believe had a temp though not recorded; pt acted listless; devel diffuse scattered papulas, mainly over face & arms;
Patient received 2 doses of Engerix-B / 03/19/2020 / 09/04/2020 / dynavax Hep B vaccine on 04/23/2021; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a 54-year-old male patient who received HBV (Engerix B adult) (batch number 933623 ?, expiry date 22nd August 2021) (GSK note:the reported batch number did not match with any GSK lot number) for prophylaxis.   Previously administered products included Engerix-B (1st dose received on 19th March 2020 batch number 933839 ? expiry date 28th February 2021).   On 4th September 2020, the patient received the 2nd dose of Engerix B adult. On 4th September 2020, unknown after receiving Engerix B adult, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: On 23rd April 2021, the patient received 1st dose of Dynavax  (Heplisav-B). The patient received the 2nd dose of Engerix B, later than the recommended schedule, which led to lengthening of vaccination schedule. The patient received the 3rd dose of Hepatitis B vaccine, later than the recommended schedule, which led to lengthening of vaccination schedule. The reported batch number 933839 and 933623 for Engerix B was captured as 933839  ? and 933623 ? respectively, since they did not match with any GSK batch number.; Reporter's Comments: (GSK note:the reported batch number did not match with any GSK lot number)
Systemic: Tasting iron in mouth-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Numbness at injection site
Fever 105.0 deg F; Broke out - Rash Red Splotches (hives) (per Mother's Report); ER visit 10-30-07 (pm) (per Mother's report); 103/07 call from Mother re: child's condition improved today.
the entire face went red/swelled up massively; the entire face went red/swelled up massively; very itchy pimple-like rash of pustules started spreading on the arms and torso; very itchy pimple-like rash of pustules started spreading on the arms and torso; very itchy pimple-like rash of pustules started spreading on the arms and torso; the tiny pustules connected and formed contiguous islands that eventually formed big scabs / excreted out yellow fluid that formed crusts over the face; blister on the temple of the face burst, leaking a lot of yellow fluid; blister on the temple of the face burst, leaking a lot of yellow fluid; the blister expanded and a few more blisters formed on the forehead and neck; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: GR8734), via an unspecified route of administration, administered in left arm on 21Apr2021 at 15:00 (at the age of 32-year-old) as a single dose for covid-19 immunization. Medical history was reported as none. The patient's concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not received any other medications within 2 weeks of vaccination. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 26Apr2021, five days after vaccination of the first dose, the patient had a blister on the temple of the face burst with leaking a lot of yellow fluid. Over the next couple of days in 2021, the blister had expanded and a few more blisters had formed on the forehead and neck. Yellow fluid had seeped out and crust on the skin of the face and neck were formed. At 18 days after vaccination, a physician prescribed one week of treatment with broad-spectrum antibiotics for suspected bacterial infection. However, the medication did not halt the progression, although bacterial culture performed from a fresh blister on day 25 showed negative bacterial growth. Over the course of days 18-25 in May2021, almost the entire face went red/swelled up massively, excreted out yellow fluid that formed crusts over the face. At 18 days after vaccination in May2021, the patient had very itchy pimple-like rash of pustules started spreading on the arms and torso. Over the next 7-10 days in May2021 the tiny pustules connected and formed contiguous islands that eventually formed big scabs. The events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Oral antibiotics, oral and topical steroids. The patient underwent lab tests and procedures on day 25 which included bacterial culture performed from a fresh blister resulting negative for bacterial growth. The clinical outcome of the events was not recovered at the time of report.   Follow-up attempts are completed. No further information is expected.
Information has been received from a physician concerning a 7 month old male who was vaccinated with a first 2 ml oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine). There was no concomitant medication. Subsequently the patient experienced diarrhea and vomiting that had resolved in six days. It was noted that remaining doses of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine) were not administered. The patient did not require an office visit for the diarrhea and vomiting. Unspecified medical attention was sought. No product quality complaint was involved. No additional information was provided. Additional information has been requested.
Two days after booster lump in left side of neck with mild pain. Two days 8 hours after booster swollen armpits, warm to touch with mild pain, Two days 12 hours mild shooting like sensation in left leg and arm.  Arm and leg pain is not consistent but frequent. Mild chest discomfort again not consistent but comes and goes. Waiting for doctor to call me at this time.
Patient under age 18 was vaccinated with Moderna 046a21a, which is a vaccine error, on 4/2/2021. He received his second vaccine  Moderna  008C21A on 4/30/2021, Troubleshooting: Original dose vaccinator/screener never validated birthdate.  Unreported as error, found in data mining. He was eligible for the second vaccine per standing orders. A policy requiring vaccinators/scribes to check age was instituted shortly after his first vaccine to prevent this from occurring again. There is a note in the chart that the second dose of vaccine was approved by contractor.